ROBERT GLASGOW: Open Payments
NPI 1154301364 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 29 payments from 10 companies in 2025. Trend: 2023 $1,089 · 2024 $1,445 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $334 |
| ABBVIE INC. | 5 | $199 |
| PFIZER INC. | 7 | $167 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $115 |
| Novo Nordisk Inc | 2 | $62 |
| Lilly USA, LLC | 3 | $51 |
| Astellas Pharma US Inc | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| ConvaTec Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: AIRSUPRA, QULIPTA, BREZTRI, NEFFY, NURTEC ODT, Ozempic, PAXLOVID, Veozah.
Industry payments across VA — which companies pay providers there.
